Right-to-Try or Right-to-Ask? Understanding Right-to-Try and FDA’s Expanded Access

rho

This webinar will explore both Right-to-Try legislation and existing Expanded Access Programs, including:

  • Understanding sponsor responsibilities under these programs and when products may be eligible for these program
  • Evaluating options such as treatment protocols, treatment INDs, and emergency use
  • Discussing development risks associated with participation in these programs